DHR : Summary for Danaher Corporation Common Stoc - Yahoo Finance

U.S. Markets closed

Danaher Corporation (DHR)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
86.13+0.05 (+0.06%)
At close: 4:03PM EST
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close86.08
Bid0.00 x
Ask0.00 x
Day's Range85.77 - 86.33
52 Week Range66.94 - 86.33
Avg. Volume2,837,503
Market Cap59.71B
PE Ratio (TTM)23.58
Earnings DateN/A
Dividend & Yield0.56 (0.65%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Danaher Corp. : DHR-US: Dividend Analysis : December 30th, 2016 (record date) : By the numbers : February 24, 2017
    Capital Cube3 days ago

    Danaher Corp. : DHR-US: Dividend Analysis : December 30th, 2016 (record date) : By the numbers : February 24, 2017

    Categories: Yahoo Finance Get free summary analysis Our analysis is based on comparing Danaher Corp. with the following peers – Thermo Fisher Scientific Inc., 3M Company, AMETEK, Inc., Agilent Technologies, Inc., Emerson Electric Co., General Electric Company, Honeywell International Inc., United Technologies Corporation, ABB Ltd. Sponsored ADR and Bio-Rad Laboratories, Inc. Class A (TMO-US, MMM-US, AME-US, A-US, EMR-US, ... Read more (Read more...)

  • PR Newswire6 days ago

    Danaher Announces Appointment of Raymond C. Stevens, Ph.D. to Danaher Board

    WASHINGTON, Feb. 21, 2017 /PRNewswire/ -- Danaher Corporation (DHR) announced today that it has appointed Raymond C. Stevens, Ph.D. to its Board of Directors. Professor Stevens is currently Provost Professor of Biological Sciences and Chemistry, and Director of The Bridge Institute, at the University of Southern California, where he has served since July 2014.  From 1999 until July 2014, he served as Professor of Molecular Biology and Chemistry with The Scripps Research Institute, a non-profit research organization.  Professor Stevens is also Founding Director of the iHuman Institute at ShanghaiTech University, and has launched multiple biotechnology companies focused on drug discovery.

  • PR Newswire6 days ago

    Danaher Announces Quarterly Dividend

    WASHINGTON, Feb. 21, 2017 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.14 per share payable on April 28, 2017 ...